Last reviewed · How we verify
LianHuaQingWen Granules
LianHuaQingWen Granules is a Small molecule drug developed by Guizhou Bailing Group Pharmaceutical Co Ltd. It is currently FDA-approved. Also known as: Lianhua Qingwen Keli.
At a glance
| Generic name | LianHuaQingWen Granules |
|---|---|
| Also known as | Lianhua Qingwen Keli |
| Sponsor | Guizhou Bailing Group Pharmaceutical Co Ltd |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LianHuaQingWen Granules CI brief — competitive landscape report
- LianHuaQingWen Granules updates RSS · CI watch RSS
- Guizhou Bailing Group Pharmaceutical Co Ltd portfolio CI
Frequently asked questions about LianHuaQingWen Granules
What is LianHuaQingWen Granules?
LianHuaQingWen Granules is a Small molecule drug developed by Guizhou Bailing Group Pharmaceutical Co Ltd.
Who makes LianHuaQingWen Granules?
LianHuaQingWen Granules is developed and marketed by Guizhou Bailing Group Pharmaceutical Co Ltd (see full Guizhou Bailing Group Pharmaceutical Co Ltd pipeline at /company/guizhou-bailing-group-pharmaceutical-co-ltd).
Is LianHuaQingWen Granules also known as anything else?
LianHuaQingWen Granules is also known as Lianhua Qingwen Keli.
What development phase is LianHuaQingWen Granules in?
LianHuaQingWen Granules is FDA-approved (marketed).
Related
- Manufacturer: Guizhou Bailing Group Pharmaceutical Co Ltd — full pipeline
- Also known as: Lianhua Qingwen Keli
- Compare: LianHuaQingWen Granules vs similar drugs
- Pricing: LianHuaQingWen Granules cost, discount & access